Nanocaged enzymes with enhanced catalytic activity and increased stability
The present disclosure describes a nanoparticle comprising a three dimensional DNA nanocage and a payload biological macromolecule, and methods of assembly thereof.
1. A nanocage comprising;
a plurality of structural members comprising a single-stranded circular DNA sequence selected from p7308, p7560, p7704, p8064, p8634, and pEGFP, wherein internal surfaces of the plurality of structural members form an inner cavity which is defined by at least three pairs of opposite walls, wherein architectural arrangement of the structural members in the three dimensional body forms an arrangement selected from the group consisting of a honeycomb lattice, a single-walled square lattice, and a double-walled square lattice, and
wherein the at least three pairs of opposite walls comprises a first pair, a second pair, and a third pair of opposite walls, and
wherein each of the first pair of opposite walls comprises a thickness which is different from the other pairs of opposite walls.
2. The nanocage of claim 1 , wherein the three dimensional body is smaller than 100 nm×100 nm×100 nm.
3. The nanocage of claim 2 , wherein the three dimensional body is smaller than 75 nm×50 nm×50 nm.
4. The nanocage of claim 1 , wherein the inner cavity of the three dimensional body measures less than 50 nm×50 nm×50 nm.
5. The nanocage of claim 1 , wherein the three dimensional body further comprises at least one nanopore.
6. The nanocage of claim 5 , wherein the at least one nanopore has a diameter of about 1 nm to about 5 nm.
7. The nanocage of claim 5 , wherein the at least one nanopore has a diameter of about 1.5 nm to about 3 nm.
8. The nanocage of claim 1 , wherein the three dimensional body comprises between 0.10 to 0.30 DNA helices per nm 2 .
9. The nanocage of claim 1 , wherein the three dimensional body comprises between 0.11 to 0.17 DNA helices per nm 2 .
10. A nanoparticle comprising:
a nanocage comprising a plurality of structural members comprising DNA in a three-dimensional lattice, wherein internal surfaces of the plurality of structural members form an inner cavity which is defined by at least three pairs of opposite walls; and
one or more payload molecules bound to internal surfaces of the inner cavity, wherein the one or more payload molecules comprise enzymes, nucleic acids, polypeptides, antibodies, phospholipids, or any combination thereof;
wherein a first structural member of the plurality of structural members is linked to a second structural member of the plurality of structural members by short bridge DNA strands,
wherein said enzymes, polypeptides, or antibodies comprise a hexahistidine sequence or a lysine residue, and
wherein the at least three pairs of opposite walls comprises a first pair, a second pair, and a third pair of opposite walls, and
wherein each of the first pair of opposite walls comprises a thickness which is different from the other pairs of opposite walls.
11. The nanoparticle of claim 10 , wherein the inner cavity encapsulates two payload molecules.
12. The nanoparticle of claim 10 , wherein the one or more payload molecules is covalently linked to internal surfaces of the inner cavity.
13. The nanoparticle of claim 10 , wherein the nanocage is configured to prevent proteolytic degradation of the trapped payload molecule.
14. The nanoparticle of claim 10 , wherein the nanocage is configured to enhance the activity of the trapped payload molecule.
15. A method of making a nanoparticle comprising, the method comprising;
trapping a payload macromolecule in an open half cage comprising a single-stranded circular DNA sequence selected from p7308, p7560, p7704, p8064, p8634, and pEGFP; and
assembling two of said half cages into a closed nanocage having an inner cavity which is defined by at least three pairs of opposite walls and nanopores; wherein the inner cavity comprises the payload macromolecule, and
wherein the at least three pairs of opposite walls comprises a first pair, a second pair, and a third pair of opposite walls, and
wherein each of the first pair of opposite walls comprises a thickness which is different from the other pairs of opposite walls.
16. The method of claim 15 , wherein the half cage comprising DNA is constructed by folding full-length single-stranded circular DNA sequence selected from p7308, p7560, p7704, p8064, p8634, and pEGFP.
17. The method of claim 15 , wherein the half cage comprises a base and two adjoined side walls protruding from the base.
18. The method of claim 15 , wherein the payload macromolecule is covalently linked to at least one of the two half cages.
19. The method of claim 15 , wherein two half cages are assembled into a closed nanocage by adding short bridge DNA strands.
20. A nanoparticle comprising:
a nanocage comprising a plurality of structural members comprising DNA in a three-dimensional lattice, wherein internal surfaces of the plurality of structural members form an inner cavity which is defined by at least three pairs of opposite walls; and
one or more payload molecules bound to internal surfaces of the inner cavity, wherein the one or more payload molecules comprise enzymes, nucleic acids, polypeptides, antibodies, phospholipids, or any combination thereof;
wherein a first structural member of the plurality of structural members is linked to a second structural member of the plurality of structural members by short bridge DNA strands, and
wherein the at least three pairs of opposite walls comprises a first pair, a second pair, and a third pair of opposite walls, and
wherein each of the first pair of opposite walls comprises a thickness which is different from the other pairs of opposite walls.